Supplementary Figure 5: Blood parameters in mCRC patients, D0 versus D15 from Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen

Emeric Limagne,Romain Euvrard,Marion Thibaudin,Cédric Rébé,Valentin Derangère,Angélique Chevriaux,Romain Boidot,Frédérique Végran, Nathalie Bonnefoy,Julie Vincent,Leila Bengrine-Lefevre,Sylvain Ladoire,Dominique Delmas,Lionel Apetoh,François Ghiringhelli

crossref（2023）

引用 0|浏览13

暂无评分

摘要

Whole blood of metastatic colorectal cancer patient (mCRC) was sample before (D0) and after chemotherapy (D15) on EDAT-K2 tubes (BD Bioscience) and a complete blood count (CBC) was performed in Clinical Biology Unit (Centre George François Leclerc).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要